| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/07/2011 | WO2011081199A1 Oral preparation having improved quality |
| 07/07/2011 | WO2011081117A1 Solid pharmaceutical composition for oral administration |
| 07/07/2011 | WO2011080722A2 Use of skin permeation and retention enhancer compound in cosmetic and pharmaceutical compositions and cosmetic and pharmaceutical products containing said compound |
| 07/07/2011 | WO2011080683A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs |
| 07/07/2011 | WO2011080595A2 Polysaccharide immunogens conjugated to e. coli carrier proteins |
| 07/07/2011 | WO2011080422A1 Method for synthesizing calixarene and/or cyclodextrin copolymers, terpolymers and tetrapolymers, and uses thereof |
| 07/07/2011 | WO2011080421A1 Method for synthesizing calixarene and/or cyclodextrin copolymers, terpolymers and tetrapolymers, and uses thereof |
| 07/07/2011 | WO2011080259A1 Lipopeptide- and lipoprotein-conjugates and its use |
| 07/07/2011 | WO2011080246A1 Oral liquid pharmaceutical composition of nifedipine |
| 07/07/2011 | WO2011080209A2 Novel antibody formulation |
| 07/07/2011 | WO2011080148A2 An aqueous intravenous nanosuspension with reduced adverse effects |
| 07/07/2011 | WO2011080103A1 Double-acylated glp-1 derivatives |
| 07/07/2011 | WO2011079800A1 Dipolar molecule-modified mesoporous silicon material, the preparation and application thereof |
| 07/07/2011 | WO2011079520A1 Polyethylene glycol-poly(lactic-co-glycolic acid)-poly(l-lysine), preparation method and use as drug/gene carrier thereof |
| 07/07/2011 | WO2011079439A1 Highly active metathesis catalysts selective for romp and rcm reactions |
| 07/07/2011 | WO2011056487A3 Stable thickener formulations |
| 07/07/2011 | WO2010072419A3 Enema preparations and their use |
| 07/07/2011 | US20110166530 Hyaluronic acid dispersion, production and use |
| 07/07/2011 | US20110166240 Ph modulated films for delivery of actives |
| 07/07/2011 | US20110166202 Formoterol/steroid bronchodilating compositions and methods of use thereof |
| 07/07/2011 | US20110166105 Antimicrobial wash and carrier solutions and uses thereof |
| 07/07/2011 | US20110166091 Compositions Containing Piperacillin and Tazobactam Useful for Injection |
| 07/07/2011 | US20110166084 Controlled release composition and method of producing the same |
| 07/07/2011 | US20110166061 Long lasting fusion peptide inhibitors for hiv infection |
| 07/07/2011 | US20110165260 Allantoin-containing skin cream |
| 07/07/2011 | US20110165256 Compositions and methods for treatment of hyperplasia |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165248 Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| 07/07/2011 | US20110165244 Bioresponsive polymer formulations for delivery of bioactive agents |
| 07/07/2011 | US20110165242 In situ gelling drug delivery system |
| 07/07/2011 | US20110165223 Antitumor Immunization by Liposomal Delivery of Vaccine to the Spleen |
| 07/07/2011 | US20110165222 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 07/07/2011 | US20110165211 Carbon dioxide external preparation, and material for formation of carbon dioxide external preparation |
| 07/07/2011 | US20110165208 Color capsule composition for cosmetics, preparation method thereof and cosmetic formulation comprising the same |
| 07/07/2011 | US20110165207 Particulate wax composites and method for the production thereof and the use thereof |
| 07/07/2011 | US20110165193 Methods for producing vaccine adjuvants |
| 07/07/2011 | US20110165192 Methods for producing vaccine adjuvants |
| 07/07/2011 | US20110165160 Neutrokine-alpha and neutrokine-alpha splice variant |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | US20110165114 Drug delivery composition |
| 07/07/2011 | US20110165113 Polymer conjugates of v681-like peptides |
| 07/07/2011 | US20110165111 Polymer conjugates of nesiritide peptides |
| 07/07/2011 | US20110165097 Compositions for percutaneous administration |
| 07/07/2011 | US20110165074 Chelating amphiphilic polymers |
| 07/07/2011 | US20110162982 Methods for producing vaccine adjuvants |
| 07/07/2011 | CA2785638A1 Melt extruded thin strips containing coated pharmaceutical actives |
| 07/07/2011 | CA2785622A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs |
| 07/07/2011 | CA2784990A1 Polylactic acid derivatives for controlled delivery of proteins or peptides |
| 07/07/2011 | CA2784757A1 Double-acylated glp-1 derivatives |
| 07/07/2011 | CA2784365A1 Low toxicity topical active agent delivery system |
| 07/07/2011 | CA2783715A1 Novel antibody formulation |
| 07/07/2011 | CA2773544A1 Core stabilized microcapsules, method of their preparation and uses thereof |
| 07/06/2011 | EP2341346A2 Methods of high-throughput screening for internalizing antibodies and metal-chelating liposomes |
| 07/06/2011 | EP2341148A2 Diagnosis and treatment of cancer |
| 07/06/2011 | EP2341077A1 Adenocarcinoma specific antibody SAM-6, and uses thereof |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2341055A1 Grafting polymerization of guar by electron beams |
| 07/06/2011 | EP2340846A1 Caspofungin formulations |
| 07/06/2011 | EP2340843A1 Methods and compositions to treat myocardial conditions |
| 07/06/2011 | EP2340841A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient |
| 07/06/2011 | EP2340833A2 Controlled release oxycodone compositions |
| 07/06/2011 | EP2340810A1 Aripiprazole injectable suspension |
| 07/06/2011 | EP2340809A2 A medicament containing fluoroquinolones |
| 07/06/2011 | EP2340271A1 Polymer-bioactive agent conjugates |
| 07/06/2011 | EP2340261A1 Amylin derivatives |
| 07/06/2011 | EP2340258A2 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes |
| 07/06/2011 | EP2340050A2 Polymer conjugates of aod-like peptides |
| 07/06/2011 | EP2340049A1 Method of acylating a peptide or protein |
| 07/06/2011 | EP2340048A1 Polymer conjugates of biphalin peptides |
| 07/06/2011 | EP2340047A1 Polymer conjugates of kiss1 peptides |
| 07/06/2011 | EP2340046A2 Polymer conjugates of ziconotide peptides |
| 07/06/2011 | EP2340045A1 Polymer conjugates of protegrin peptides |
| 07/06/2011 | EP2340044A1 Pegylated opioids with low potential for abuse |
| 07/06/2011 | EP2340043A1 Topical composition comprising a combination of at least two penetration enhancing agents |
| 07/06/2011 | EP2340041A2 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 07/06/2011 | EP2340036A1 Induction of mucosal immune responses by mucosal delivery pentabody complex (mdpc) |
| 07/06/2011 | EP2340033A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 07/06/2011 | EP2340016A2 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
| 07/06/2011 | EP1767575B1 Gel-form water-absorbing material |
| 07/06/2011 | EP1611170B1 Macromolecules auto-assembled and photopolymerised around carbon nanotubes a method for production and application thereof |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1146906B1 Mucosal delivery system |
| 07/06/2011 | EP0707478B1 Improved nicotine lozenge |
| 07/06/2011 | CN1871022B Peptides and compounds that bind to a receptor |
| 07/06/2011 | CN102119034A Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 07/06/2011 | CN102119023A Unit dosage of apadenoson |
| 07/06/2011 | CN102119022A Pharmaceutical compositions |
| 07/06/2011 | CN102115448A Admantyl quaternary ammonium base and preparation method thereof |
| 07/06/2011 | CN102114271A Multi-medicament loaded calcium phosphate cement powder |
| 07/06/2011 | CN102114248A Poly (2-hydroxyl-3-(2-hydroxyethylamino) propyl methacrylate) (PGEA)-isoplyacid nano compound antitumor medicament and preparation method thereof |
| 07/06/2011 | CN102114247A Conjugate of SSA, PEG and anticancer drugs and preparation thereof |
| 07/06/2011 | CN102114246A Amphiphilic polysaccharide derivative vector for specific medicine release in organism focusas well as preparation and application of pharmaceutical composition thereof |
| 07/06/2011 | CN102114245A Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof |
| 07/06/2011 | CN102114112A Effervescent tablet for improving immunity and preparation method thereof |
| 07/06/2011 | CN102114082A Compound giant knotweed emulsion for preventing livestock and poultry infection |
| 07/06/2011 | CN102114072A Red sage root extract sustained-release micropills and preparation method and application thereof |
| 07/06/2011 | CN102114069A Traditional Chinese medicine health care capsules with functions of moisturizing intestine and relaxing bowels and preparation method |
| 07/06/2011 | CN102114048A Production method of bee pollen soft capsules for treating fatty liver |
| 07/06/2011 | CN102114046A Preparation method of oviductus ranae preparation |
| 07/06/2011 | CN102114012A Medicinal composition for treating heart cerebrovascular diseases as well as preparation method and application thereof |